Keqi Song
Overview
Explore the profile of Keqi Song including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang C, Li Q, Song K, Wang W, Zhang N, Dai L, et al.
Nanoscale Adv
. 2024 Aug;
6(16):4082-4093.
PMID: 39114142
Resistance to platinum-based chemotherapy is the major cause of poor prognosis and cancer-associated mortality in ovarian cancer patients, so novel therapeutic strategies to restore platinum sensitivity are needed to improve...
2.
Xie H, Liu N, Zhang Q, Zhong H, Guo L, Zhao X, et al.
Nature
. 2023 Nov;
623(7989):964-971.
PMID: 38030779
Plasmas can generate ultra-high-temperature reactive environments that can be used for the synthesis and processing of a wide range of materials. However, the limited volume, instability and non-uniformity of plasmas...
3.
Wang C, Ye T, Wang W, Song K, Zhu J, Dai L, et al.
Exp Hematol Oncol
. 2022 Nov;
11(1):102.
PMID: 36384540
Unlike many solid tumors, epithelial ovarian cancer (EOC) has a clear metastatic predilection to the adipocyte-rich niche, especially the omentum. However, the underlying mechanism driving this process remains incomplete. Here...
4.
Dai L, Wang C, Wang W, Song K, Ye T, Zhu J, et al.
Open Med (Wars)
. 2022 Feb;
17(1):229-238.
PMID: 35178477
Epithelial ovarian cancer (EOC) is the leading cause of deaths due to cancer in women. Adipocytes have been suggested to play a key role in the stimulation of EOC growth....
5.
Cui X, Song K, Lu X, Feng W, Di W
ACS Omega
. 2021 May;
6(17):11669-11678.
PMID: 34056322
Ovarian cancer is highly aggressive and has high rates of recurrence and metastasis. Due to the limited effects of current treatments, it is necessary to conduct research and develop new...
6.
Dai L, Wang W, Liu Y, Song K, Di W
Ann Transl Med
. 2021 May;
9(8):645.
PMID: 33987343
Background: Epithelial ovarian cancer (EOC) is the leading cause of death from female cancers. In our previous study, sphingosine kinase 2 (SphK2) inhibitor was shown to display anti-EOC activities. The...
7.
Dai L, Wang C, Song K, Wang W, Di W
J Ovarian Res
. 2021 May;
14(1):62.
PMID: 33931106
Background: Adipocytes, active facilitators of epithelial ovarian cancer (EOC) growth, have been implicated in the link between obesity and EOC. However, the current understanding of the mechanisms underlying adipocyte-induced EOC...
8.
Dai L, Song K, Di W
J Ovarian Res
. 2020 Sep;
13(1):115.
PMID: 32967712
There is growing evidence that adipocytes play important roles in the progression of multiple cancers. Moreover, in obesity, adipocytes alter their original functions and contribute to the metabolic and inflammatory...
9.
Song K, Dai L, Long X, Wang W, Di W
Sci Rep
. 2020 Aug;
10(1):13834.
PMID: 32796926
Follicle-stimulating hormone (FSH) is closely related to the pathogenesis and progression of epithelial ovarian cancer (EOC). However, until now, knowledge relating to FSH-driven signalling pathways that lead to the growth...
10.
Long X, Song K, Hu H, Tian Q, Wang W, Dong Q, et al.
J Exp Clin Cancer Res
. 2019 Aug;
38(1):345.
PMID: 31391118
Background: Epithelial ovarian cancer (EOC) is the malignant tumor of the female reproductive system with the highest fatality rate. Tolerance of chemotherapeutic drugs like cisplatin (DDP) occurring in very early...